Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Sep:96:111484.
doi: 10.1016/j.jclinane.2024.111484. Epub 2024 May 21.

Using the nociception level index to compare the intraoperative antinociceptive effect of propofol and sevoflurane during clinical and experimental noxious stimulus in patients under general anesthesia

Affiliations
Randomized Controlled Trial

Using the nociception level index to compare the intraoperative antinociceptive effect of propofol and sevoflurane during clinical and experimental noxious stimulus in patients under general anesthesia

Corentin Monfort et al. J Clin Anesth. 2024 Sep.

Abstract

Study: Propofol and sevoflurane are two anesthetic agents widely used to induce and maintain general anesthesia (GA). Their intrinsic antinociceptive properties remain unclear and are still debated.

Objective: To determine whether propofol presents stronger antinociceptive properties than sevoflurane using intraoperative clinical and experimental noxious stimulations and evaluating postoperative pain outcomes.

Design: A prospective randomized monocentric trial.

Setting: Perioperative care.

Patients: 60 adult patients with ASA status I to III who underwent elective abdominal laparoscopic surgery under GA were randomized either in propofol or sevoflurane group to induce and maintain GA.

Interventions: We used clinical and experimental noxious stimulations (intubation, tetanic stimulation) to assess the antinociceptive properties of propofol and sevoflurane in patients under GA and monitored using the NOL index, BIS index, heart rate, and mean arterial blood pressure.

Measurements: We measured the difference in the NOL index alterations after intubation and tetanic stimulation during either intravenous anesthesia (propofol) or inhaled anesthesia (sevoflurane). We also intraoperatively measured the NOL index and remifentanil consumption and recorded postoperative pain scores and opioid consumption in the post-anesthesia care unit. Intraoperative management was standardized by targeting similar values of depth of anesthesia (BIS index), hemodynamic (HR and MAP), NOL index values (below the threshold of 20), same multimodal analgesia and type of surgery.

Main results: We found the antinociceptive properties of propofol and sevoflurane similar. The only minor difference was after tetanic stimulation: the delta NOL was higher in the sevoflurane group (39 ± 13 for the propofol group versus 47 ± 15 for sevoflurane; P = 0.04). Intraoperative and postoperative pain outcomes and opioid consumption were similar between groups.

Conclusions: Despite a precise intraoperative experimental and clinical protocol using the NOL index, propofol does not provide a higher level of antinociception during anesthesia or analgesia after surgery when compared to sevoflurane. Anesthesiologists may prefer propofol over sevoflurane to reduce PONV or anesthesia-related pollution, but not for superior antinociceptive properties.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Dr. Philippe Richebé received honorariums in the past 5 years from several companies for conducting educational lectures (Medtronic Canada, Merck Canada, Medasense Ltd., Avir Pharma). Dr. Philippe Richebé received grants in the past 5 years from companies in the form of Investigator Initiated Trial grants (Medasense, Medtronic, Merck). There was no conflict with the present work. This work was sponsored and funded by the Department of Anesthesia and Pain Medicine at Maisonneuve-Rosemont Hospital. The results of this study were presented at the French Society of Anesthesia and Reanimation meeting in 2022 and received the 2nd prize at the resident competition of the Association of Anesthesiology of Quebec in 2022, and the third prize of the resident research competition of University of Montreal in 2022.

References

Publication types

MeSH terms